32 mg multi-dose injection pen. GIP, GLP-1 and glucagon receptor agonist for subcutaneous injection. Exclusively for research and analytical purposes.

Every Body Pharm pen in one place: pre-filled, dose-validated and sealed. Filter by research goal or availability. Strictly for research and analytical use.
32 mg multi-dose injection pen. GIP, GLP-1 and glucagon receptor agonist for subcutaneous injection. Exclusively for research and analytical purposes.

64 mg multi-dose injection pen. GIP, GLP-1 and glucagon receptor agonist for subcutaneous injection. Exclusively for research and analytical purposes.

1000 mg of NAD+ (nicotinamide adenine dinucleotide) in a multi-dose pen for subcutaneous injection. The dial is marked at 20, 30, 40 and 50 mg, up to 200 mg a day.

GHK-Cu copper peptide for subcutaneous injection. Body Pharm premium research-grade purity.

Multi-dose injection pen combining BPC-157 and TB-500. Body Pharm premium research-grade purity.

Multi-dose injection pen with 60 mg of tirzepatide. Dual GIP and GLP-1 receptor agonist for subcutaneous injection. Exclusively for research and analytical purposes.

Multi-dose injection pen with 32 mg of tesamorelin. Growth hormone-releasing hormone (GHRH) analogue for subcutaneous injection. Exclusively for research and analytical purposes.

Multi-dose injection pen with 32 mg of MOTS-c. Mitochondria-encoded peptide for subcutaneous injection. Exclusively for research and analytical purposes.

Multi-dose injection pen with 20 mg of CJC-1295 and ipamorelin. GHRH analogue combined with a selective growth hormone secretagogue, for subcutaneous injection. Exclusively for research and analytical purposes.

Multi-dose injection pen with 20 mg of melanotan II. Melanocortin receptor agonist for subcutaneous injection. Exclusively for research and analytical purposes.

We use cookies and similar technologies for analytics and marketing to improve our service. Strictly necessary cookies are always on. Full details are in our privacy policy.